$AYTU
AYTU BIOPHARMA, INC Stock $aytu

$aytu Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000114420417007057 Filed on February 09, 2017

Income Statement

Concept	2017 Q1	2016 Q4	2016 Q2
Revenue	$893.5K	$794.2K	$940.0K
YoY Change	33.66%	69.26%	422.22%
Cost Of Revenue	$324.4K	$551.3K	$330.0K
YoY Change	-4.8%	125.85%	266.67%
Gross Profit	$569.1K	$242.9K	$600.0K
YoY Change	73.64%	7.89%	566.67%
Gross Profit Margin	63.69%	30.58%	63.83%
Selling, General & Admin	$4.385M	$3.642M	$3.150M
YoY Change	102.53%	115.81%	125.0%
% of Gross Profit	770.53%	1499.65%	525.0%
Research & Development	$279.0K	$263.5K	$2.870M
YoY Change	-75.6%	-79.87%	237.65%
% of Gross Profit	49.03%	108.47%	478.33%
Depreciation & Amortization	$27.00K	$26.00K	$440.0K
YoY Change	50.0%	116.67%	780.0%
% of Gross Profit	4.74%	10.7%	73.33%
Operating Expenses	$5.753M	$4.993M	$6.410M
YoY Change	47.68%	43.34%	186.16%
Operating Profit	-$4.860M	-$4.199M	-$5.810M
YoY Change	50.58%	39.31%	170.23%
Interest Expense	$80.72K	$388.1K	-$2.000M
YoY Change	-98.02%	61.56%
% of Operating Profit
Other Income/Expense, Net	-$356.5K	-$618.5K
YoY Change	-91.19%	94.26%
Pretax Income	-$5.220M	-$4.820M	-$15.30M
YoY Change	-28.24%	44.64%	608.33%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$5.216M	-$4.817M	-$15.30M
YoY Change	-28.29%	44.56%	608.33%
Net Earnings / Revenue	-583.78%	-606.57%	-1627.66%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.908B	-$2.454B	-$20.25B
COMMON SHARES
Basic Shares Outstanding	10.85M shares	10.85M shares	44.86M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q1	2016 Q4	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.500M	$6.500M	$9.100M
YoY Change	-59.77%	-40.91%	22.97%
Cash & Equivalents	$3.470M	$5.200M	$8.054M
Short-Term Investments	$0.00	$1.300M	$1.000M
Other Short-Term Assets	$400.0K	$700.0K	$300.0K
YoY Change	-63.64%	-22.22%	-40.0%
Inventory	$200.0K	$439.0K	$524.7K
Prepaid Expenses
Receivables	$300.0K	$582.4K	$162.4K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.400M	$8.158M	$10.12M
YoY Change	-57.84%	-36.27%	25.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$300.0K	$292.2K	$231.4K
YoY Change	52.37%	192.17%	679.07%
Goodwill		$221.0K	$221.0K
YoY Change			198.65%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$9.561M	$200.0K	$10.55M
YoY Change	4680.38%	-33.33%
Total Long-Term Assets	$11.48M	$13.35M	$14.22M
YoY Change	-0.61%	15.07%	40.22%
TOTAL ASSETS
Total Short-Term Assets	$4.400M	$8.158M	$10.12M
Total Long-Term Assets	$11.48M	$13.35M	$14.22M
Total Assets	$15.90M	$21.51M	$24.34M
YoY Change	-27.68%	-11.86%	33.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.409M	$2.400M	$2.323M
YoY Change	17.41%	118.18%	93.55%
Accrued Expenses	$1.051M	$500.0K	$1.197M
YoY Change	31.35%	0.0%	498.55%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.354M	$7.000M	$10.10M
YoY Change	4.65%	150.0%	583.85%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$4.000M	$4.100M	$4.200M
YoY Change	233.33%	192.86%	281.82%
Total Long-Term Liabilities	$4.000M	$4.100M	$4.200M
YoY Change	233.33%	-34.92%	281.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.354M	$7.000M	$10.10M
Total Long-Term Liabilities	$4.000M	$4.100M	$4.200M
Total Liabilities	$7.395M	$11.10M	$14.26M
YoY Change	67.32%	20.65%	455.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$62.32M		-$46.56M
YoY Change	99.33%		153.31%
Common Stock	$70.84M		$56.65M
YoY Change	45.08%		45.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.521M	$10.40M	$10.09M
YoY Change
Total Liabilities & Shareholders Equity	$15.92M	$21.50M	$24.34M
YoY Change	-27.6%	-11.89%	33.86%

Cashflow Statement

Concept	2017 Q1	2016 Q4	2016 Q2
OPERATING ACTIVITIES
Net Income	-$5.216M	-$4.817M	-$15.30M
YoY Change	-28.29%	44.56%	608.33%
Depreciation, Depletion And Amortization	$27.00K	$26.00K	$440.0K
YoY Change	50.0%	116.67%	780.0%
Cash From Operating Activities	-$2.390M	-$2.840M	-$2.670M
YoY Change	0.42%	-17.68%	50.0%
INVESTING ACTIVITIES
Capital Expenditures	$1.990M	-$2.040M	-$1.090M
YoY Change	-2942.86%	1469.23%
Acquisitions
YoY Change
Other Investing Activities	-$3.270M	-$250.0K	-$3.470M
YoY Change		-53.7%	247.0%
Cash From Investing Activities	-$1.280M	-$2.290M	-$4.560M
YoY Change	1500.0%	246.97%	356.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.920M	7.600M	6.610M
YoY Change	1029.41%	52.0%	-23.58%
NET CHANGE
Cash From Operating Activities	-2.390M	-2.840M	-2.670M
Cash From Investing Activities	-1.280M	-2.290M	-4.560M
Cash From Financing Activities	1.920M	7.600M	6.610M
Net Change In Cash	-1.750M	2.470M	-620.0K
YoY Change	-23.58%	177.53%	-110.56%
FREE CASH FLOW
Cash From Operating Activities	-$2.390M	-$2.840M	-$2.670M
Capital Expenditures	$1.990M	-$2.040M	-$1.090M
Free Cash Flow	-$4.380M	-$800.0K	-$1.580M
YoY Change	89.61%	-75.9%	-11.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q2	us-gaap	Inventory Net InventoryNet	524707	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	436573	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	215558	USD
CY2016Q4	aytu	Prepaid Research And Development Related Party PrepaidResearchAndDevelopmentRelatedParty	121983	USD
CY2016Q2	aytu	Prepaid Research And Development Related Party PrepaidResearchAndDevelopmentRelatedParty	121983	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	162427	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	3483214	USD
CY2016Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-497164	USD
CY2015Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	156814	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	596434	USD
	us-gaap	Net Income Loss NetIncomeLoss	-10541576	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	607234	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	509996	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1425133	USD
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	1350	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	10120227	USD
CY2016Q4	us-gaap	Indefinite Lived Contractual Rights IndefiniteLivedContractualRights	1249875	USD
CY2016Q2	us-gaap	Indefinite Lived Contractual Rights IndefiniteLivedContractualRights	1353375	USD
CY2016Q4	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	178806	USD
CY2016Q2	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	194472	USD
CY2016Q4	us-gaap	Goodwill Goodwill	221000	USD
CY2016Q2	us-gaap	Goodwill Goodwill	221000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	283944	USD
CY2015Q4	aytu	Products And Services Revenue ProductsAndServicesRevenue	447786	USD
CY2016Q4	us-gaap	Licenses Revenue LicensesRevenue	0	USD
CY2015Q4	us-gaap	Licenses Revenue LicensesRevenue	21428	USD
CY2016Q4	us-gaap	Revenues Revenues	794172	USD
CY2015Q4	us-gaap	Revenues Revenues	469214	USD
CY2016Q4	us-gaap	Cost Of Revenue CostOfRevenue	551293	USD
CY2015Q4	us-gaap	Cost Of Revenue CostOfRevenue	244100	USD
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	263457	USD
CY2015Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1308460	USD
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.8
CY2016Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.61
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-318380	USD
CY2016Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-618492	USD
CY2015Q4	us-gaap	Interest Expense InterestExpense	240214	USD
CY2016Q4	us-gaap	Interest Expense InterestExpense	388085	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-3014000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4198694	USD
CY2015Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1687724	USD
CY2016Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3642332	USD
CY2015Q4	aytu	Research And Development Related Party ResearchAndDevelopmentRelatedParty	47998	USD
CY2016Q4	aytu	Research And Development Related Party ResearchAndDevelopmentRelatedParty	47998	USD
CY2016Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	266757	USD
CY2015Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-78166	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	4992866	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	582393	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	438966	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	296611	USD
CY2016Q4	us-gaap	Assets Assets	21506168	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	231430	USD
CY2016Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2888	USD
CY2016Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2888	USD
CY2016Q4	aytu	Prepaid Research And Development Related Party Noncurrent PrepaidResearchAndDevelopmentRelatedPartyNoncurrent	152479	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2445849	USD
CY2016Q2	aytu	Prepaid Research And Development Related Party Noncurrent PrepaidResearchAndDevelopmentRelatedPartyNoncurrent	213471	USD
CY2016Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3519711	USD
CY2016Q2	us-gaap	Assets Assets	24343007	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	8157669	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	292169	USD
CY2016Q4	aytu	Core And Developed Technology Net CoreAndDevelopedTechnologyNet	1076903	USD
CY2016Q2	aytu	Core And Developed Technology Net CoreAndDevelopedTechnologyNet	1159736	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	196148	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-8168579	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2794876	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	419966	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1722965	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	750000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	221015	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-434231	USD
	aytu	Increase Decrease In Accrued Compensation IncreaseDecreaseInAccruedCompensation	-681432	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44876	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	24247	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	631481	USD
	aytu	Amortization Of Prepaid Research And Development Due To Related Parties AmortizationOfPrepaidResearchAndDevelopmentDueToRelatedParties	60992	USD
	aytu	Fixed Assets Included In Accounts Payable FixedAssetsIncludedInAccountsPayable	61241	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1425133	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	156814	USD
CY2016Q4	us-gaap	Depreciation Depreciation	26000	USD
CY2015Q4	us-gaap	Depreciation Depreciation	12000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	157000	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	112000	USD
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet	794000	USD
CY2015Q4	us-gaap	Sales Revenue Net SalesRevenueNet	448000	USD
CY2016Q4	us-gaap	License And Maintenance Revenue LicenseAndMaintenanceRevenue	0	USD
CY2015Q4	us-gaap	License And Maintenance Revenue LicenseAndMaintenanceRevenue	21000	USD
CY2016Q2	us-gaap	Deferred Revenue DeferredRevenue	426000	USD
CY2016Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	1272000	USD
CY2015Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5200000	USD
CY2015Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	401000	USD
CY2015Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	103000	USD
CY2015Q3	aytu	Placement Agents Cash Fee Percentage PlacementAgentsCashFeePercentage	0.08	pure
	aytu	Placement Agents Cash Fee Percentage PlacementAgentsCashFeePercentage	0.08	pure
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	20000	USD
CY2016Q1	aytu	Warrants Issued To Purchase Of Common Stock WarrantsIssuedToPurchaseOfCommonStock	22254	shares
CY2016Q1	aytu	Warrants Exercise Price Per Share WarrantsExercisePricePerShare	7.80
CY2016Q2	aytu	Warrants Issued To Purchase Of Common Stock WarrantsIssuedToPurchaseOfCommonStock	22564	shares
CY2016Q2	aytu	Warrants Exercise Price Per Share WarrantsExercisePricePerShare	4.80
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10845566	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3741944	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	318000	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	322302	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	441999	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	17646	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	323755	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.23
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.01
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.99
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.4
CY2016Q4	aytu	Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrant	1253345	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	746655	shares
CY2016Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	14222780	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1188308	shares
CY2016Q2	aytu	Share Based Compensation Share Warrants Outstanding ShareBasedCompensationShareWarrantsOutstanding	2201627	shares
CY2016Q4	aytu	Share Based Compensation Share Warrants Outstanding ShareBasedCompensationShareWarrantsOutstanding	8711354	shares
	aytu	Share Based Compensation Share Warrants Issued As Part Of Settlement ShareBasedCompensationShareWarrantsIssuedAsPartOfSettlement	88032	shares
	aytu	Share Based Compensation Share Warrants Issued As Part Of Settlement Weighted Average Exercise Price ShareBasedCompensationShareWarrantsIssuedAsPartOfSettlementWeightedAverageExercisePrice	4
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016Q4	aytu	Share Based Compensation Share Warrants Outstanding Weighted Average Exercise Price ShareBasedCompensationShareWarrantsOutstandingWeightedAverageExercisePrice	2.98
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.52
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y1M6D
	aytu	Unrecognized Share Based Compensation Expenses UnrecognizedShareBasedCompensationExpenses	1435000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y3M4D
CY2016Q2	aytu	Share Based Compensation Share Warrants Outstanding Weighted Average Exercise Price ShareBasedCompensationShareWarrantsOutstandingWeightedAverageExercisePrice	6.19
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	AYTU BIOSCIENCE, INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001385818
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	AYTU
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10845566	shares
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2016Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	13348499	USD
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10845566	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3741944	shares
CY2016Q4	aytu	Products And Services Revenue ProductsAndServicesRevenue	794172	USD
	aytu	Products And Services Revenue ProductsAndServicesRevenue	1492152	USD
	aytu	Products And Services Revenue ProductsAndServicesRevenue	913742	USD
	us-gaap	Licenses Revenue LicensesRevenue	0	USD
	us-gaap	Licenses Revenue LicensesRevenue	42857	USD
	us-gaap	Revenues Revenues	1492152	USD
	us-gaap	Revenues Revenues	956599	USD
	us-gaap	Cost Of Revenue CostOfRevenue	743217	USD
	us-gaap	Cost Of Revenue CostOfRevenue	281425	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	495479	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2164334	USD
	aytu	Research And Development Related Party ResearchAndDevelopmentRelatedParty	95996	USD
	aytu	Research And Development Related Party ResearchAndDevelopmentRelatedParty	95996	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9347082	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3250903	USD
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	101544	USD
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	175068	USD
CY2016Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	437014	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	874029	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	165936	USD
	us-gaap	Operating Expenses OperatingExpenses	11657347	USD
	us-gaap	Operating Expenses OperatingExpenses	6133662	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10165195	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5177063	USD
	us-gaap	Interest Expense InterestExpense	803465	USD
	us-gaap	Interest Expense InterestExpense	353467	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-78038	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	230936	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-376381	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-431505	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5910910	shares
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.78
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.72
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-4817186	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-3332380	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5608568	USD
	aytu	Adjustments To Additional Paid In Capital Warrants Issued In Connection With Equity Financing AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConnectionWithEquityFinancing	3470646	USD
	aytu	Adjustments To Additional Paid In Capital Warrants Issued In Connection With Equity Financing To Placement Agents For Over Allotment Option AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConnectionWithEquityFinancingToPlacementAgentsForOverAllotmentOption	172629	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	250887	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	242427	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	147805	USD
	aytu	Amortization Of Prepaid Research And Development Due To Related Parties AmortizationOfPrepaidResearchAndDevelopmentDueToRelatedParties	60991	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	131408	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-85741	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	613673	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	370656	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-126781	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	38451	USD
	aytu	Increase Decrease In Accrued Compensation IncreaseDecreaseInAccruedCompensation	296081	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	161988	USD
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	-10245	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-42857	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5607030	USD
	aytu	Payments For Deposits Investing Activities PaymentsForDepositsInvestingActivities	0	USD
	aytu	Payments For Deposits Investing Activities PaymentsForDepositsInvestingActivities	-1998	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	125161	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	540000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-663163	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2000000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5175000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	298322	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	9876678	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3606485	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7353061	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10959546	USD
	aytu	Warrant Derivative Liability Related To Issuance Of Convertible Promissory Notes WarrantDerivativeLiabilityRelatedToIssuanceOfConvertiblePromissoryNotes	102931	USD
	aytu	Primsol Business Purchase Included In Primsol Payable PrimsolBusinessPurchaseIncludedInPrimsolPayable	1077000	USD
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	USD
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	5000000	USD
	aytu	Primsol Business Purchase Included In Primsol Payable Gross PrimsolBusinessPurchaseIncludedInPrimsolPayableGross	1250000	USD
	aytu	Primsol Business Purchase Included In Primsol Payable Gross PrimsolBusinessPurchaseIncludedInPrimsolPayableGross	1250000	USD
	us-gaap	Standardized Measure Of Discounted Future Net Cash Flow Relating To Proved Oil And Gas Reserves Accretion Of Discount StandardizedMeasureOfDiscountedFutureNetCashFlowRelatingToProvedOilAndGasReservesAccretionOfDiscount	173000	USD
	us-gaap	Standardized Measure Of Discounted Future Net Cash Flow Relating To Proved Oil And Gas Reserves Accretion Of Discount StandardizedMeasureOfDiscountedFutureNetCashFlowRelatingToProvedOilAndGasReservesAccretionOfDiscount	173000	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	997865	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M29D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y2M16D
	aytu	Share Based Compensation Share Warrants Issued On Registered Offering ShareBasedCompensationShareWarrantsIssuedOnRegisteredOffering	6020245	shares
	aytu	Share Based Compensation Share Warrants Issued On Placement Agents For Registered Offering ShareBasedCompensationShareWarrantsIssuedOnPlacementAgentsForRegisteredOffering	401450	shares
	aytu	Share Based Compensation Share Warrants Issued On Registered Offeringweighted Average Exercise Price ShareBasedCompensationShareWarrantsIssuedOnRegisteredOfferingweightedAverageExercisePrice	1.86
CY2016Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	173000	USD
	us-gaap	Debt Instrument Convertible Terms Of Conversion Feature DebtInstrumentConvertibleTermsOfConversionFeature	At the insistence of the underwriters of the offering, all outstanding noteholders had signed lockup agreements which granted them an extra 10% on the conversion, increasing it to 130% of shares calculated by dividing such Note balance by $4.80
CY2016Q2	aytu	Warrants Exercisable Term WarrantsExercisableTerm	P5Y
	aytu	Share Based Compensation Share Warrants Issued On Placement Agents For Registered Offeringweighted Average Exercise Price ShareBasedCompensationShareWarrantsIssuedOnPlacementAgentsForRegisteredOfferingweightedAverageExercisePrice	1.86
CY2016	aytu	Class Of Warrant Or Rights Weighted Average Remaining Contractual Term ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm	P4Y8M16D
	aytu	Class Of Warrant Or Rights Weighted Average Remaining Contractual Term ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm	P4Y6M4D
CY2016Q4	us-gaap	Contractual Obligation ContractualObligation	8596000	USD
CY2016Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	4750000	USD
CY2016Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	743000	USD
CY2016Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	603000	USD
CY2016Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	2500000	USD
CY2016Q4	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	0	USD
CY2016Q4	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	0	USD
CY2016Q4	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	35000	USD
CY2015Q4	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	34000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	70000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	51000	USD
CY2016Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1041000	USD
	us-gaap	Depreciation Depreciation	45000	USD
	us-gaap	Depreciation Depreciation	19000	USD
CY2016Q4	us-gaap	Investment Owned Unrecognized Unrealized Appreciation InvestmentOwnedUnrecognizedUnrealizedAppreciation	231000	USD
CY2016Q4	us-gaap	Investment Owned Unrecognized Unrealized Depreciation InvestmentOwnedUnrecognizedUnrealizedDepreciation	0	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1492000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	914000	USD
	us-gaap	License And Maintenance Revenue LicenseAndMaintenanceRevenue	0	USD
	us-gaap	License And Maintenance Revenue LicenseAndMaintenanceRevenue	43000	USD
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On June 8, 2015, we reincorporated as a domestic Delaware corporation under Delaware General Corporate Law and changed our name from Rosewind Corporation to Aytu BioScience, Inc., and effected a reverse stock split in which each common stockholder received one share of common stock for every 12.174 shares outstanding. On June 30, 2016, Aytu effected another reverse stock split in which each common stockholder received one share of common stock for every 12 shares outstanding (herein referred to collectively as the Reverse Stock Splits). All share and per share amounts in this report have been adjusted to reflect the effect of these Reverse Stock Splits.
CY2016Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	1041000	USD
	aytu	Payments For Registered Offering Costs PaymentsForRegisteredOfferingCosts	997865	USD
	aytu	Payments For Registered Offering Costs PaymentsForRegisteredOfferingCosts	0	USD
	aytu	Warrant Derivative Liability Related To Issuance Of Convertible Promissory Notes WarrantDerivativeLiabilityRelatedToIssuanceOfConvertiblePromissoryNotes		USD
	aytu	Primsol Business Purchase Included In Primsol Payable PrimsolBusinessPurchaseIncludedInPrimsolPayable		USD
	aytu	Stock And Issued During Period Value StockAndIssuedDuringPeriodValue	3671581	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	596434	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	aytu	Issuance Of Common Stock To Executives IssuanceOfCommonStockToExecutives	509996	USD
	aytu	Issuance Of Common Stock To Executives IssuanceOfCommonStockToExecutives	0	USD
	aytu	Fixed Assets Included In Accounts Payable FixedAssetsIncludedInAccountsPayable	7708	USD
	aytu	Adjustments To Additional Paid In Capital Warrants Issued In Connection With Equity Financing To Placement Agents Noncash Issuance Costs AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConnectionWithEquityFinancingToPlacementAgentsNoncashIssuanceCosts	292630	USD
	aytu	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	8602500	USD
	aytu	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2852	USD
	aytu	Warrants Issued In Connection With Equity Financing To Placement Agents WarrantsIssuedInConnectionWithEquityFinancingToPlacementAgents	292630	USD
	aytu	Warrants Issued In Connection With Equity Financing To Placement Agents WarrantsIssuedInConnectionWithEquityFinancingToPlacementAgents	0	USD
CY2016Q4	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3000	USD
CY2016Q4	aytu	Number Of Units Sold NumberOfUnitsSold	5735000	shares
CY2016Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.86
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.77
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.73
CY2016Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.50

Files In Submission

Name	View Source	Status
0001144204-17-007057-index-headers.html	Edgar Link	pending
0001144204-17-007057-index.html	Edgar Link	pending
0001144204-17-007057.txt	Edgar Link	pending
0001144204-17-007057-xbrl.zip	Edgar Link	pending
aytu-20161231.xml	Edgar Link	completed
aytu-20161231.xsd	Edgar Link	pending
aytu-20161231_cal.xml	Edgar Link	unprocessable
aytu-20161231_def.xml	Edgar Link	unprocessable
aytu-20161231_lab.xml	Edgar Link	unprocessable
aytu-20161231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v458001_10q.htm	Edgar Link	pending
v458001_ex31-1.htm	Edgar Link	pending
v458001_ex31-2.htm	Edgar Link	pending
v458001_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AYTU
AYTU BIOPHARMA, INC Stock $aytu

2017 Q1 Form 10-Q Financial Statement

#000114420417007057 Filed on February 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU AYTU BIOPHARMA, INC Stock $aytu

2017 Q1 Form 10-Q Financial Statement

#000114420417007057 Filed on February 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU
AYTU BIOPHARMA, INC Stock $aytu